Pharmaceutical composition comprising combination of Chondroitin sulfate and diacerein and their use in the treatment of osteoarthritis and related diseases

摘要

The invention refers to a pharmaceutical component formed by the synergistic action of an anti arthritis agent (collectively referred to as sulfuric acid condoritina) and an interleucine-1 inhibitor (collectively referred to as diacereina), as well as an acceptable precursor chemical on drugs, The same dosage unit is made after oral administration, which helps to control and treat osteoarthritis and related diseases, can produce greater therapeutic effect, accelerate the efficacy in a shorter time, and reduce pain,Changes in inflammation and disease of the articular cartilage structure, as well as a reduced risk of serious complications and / or side effects.